Level Biotechnology Financial Flexibility Index
Level Biotechnology financial flexibility index. Level Biotechnology (3118) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of NT$16.26 Million (operating CF NT$11.81 Million minus capex NT$4.44 Million) represents 0% of total liabilities (NT$237.03 Million). See Level Biotechnology (3118) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Level Biotechnology (2017–2024)
Financial flexibility index of Level Biotechnology from 2017 to 2024. Historical Financial Flexibility Index trend for Level Biotechnology across 8 annual periods. Check how high is Level Biotechnology's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Level Biotechnology Financial Flexibility Index by Year (2017–2024)
Level Biotechnology financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Level Biotechnology. For the full cash flow conversion analysis, see Level Biotechnology cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | NT$287.77 Million | NT$64.10 Million | NT$267.19 Million | ▲ +277.8% |
| 2023 | 0.29x | NT$77.88 Million | NT$70.21 Million | NT$273.20 Million | ▲ +7.2% |
| 2022 | 0.27x | NT$71.81 Million | NT$65.07 Million | NT$270.13 Million | ▼ -60.9% |
| 2021 | 0.68x | NT$165.10 Million | NT$155.95 Million | NT$242.78 Million | ▲ +93.1% |
| 2020 | 0.35x | NT$85.77 Million | NT$83.23 Million | NT$243.56 Million | ▼ -25.3% |
| 2019 | 0.47x | NT$111.45 Million | NT$109.02 Million | NT$236.43 Million | ▲ +192.3% |
| 2018 | 0.16x | NT$29.29 Million | NT$26.77 Million | NT$181.60 Million | ▼ -58.8% |
| 2017 | 0.39x | NT$82.12 Million | NT$71.29 Million | NT$210.03 Million | — |